
Chemical and Pharmaceutical Bulletin p. 452 - 457 (1998)
Update date:2022-08-04
Topics:
Tsuda, Yuko
Wanaka, Keiko
Tada, Mayako
Okamoto, Shosuke
Hijikata-Okunomiya, Akiko
Okada, Yoshio
The synthetic plasma kallikrein (PK) inhibitor trans-4- aminomethylcyclohexanecarbonylphenylalanine-4-carboxymethylanilide (PKSI- 527) consists of three parts. Each part was replaced by analogues in an attempt to improve the potency and the selectivity of PKSI-527. Among the peptides examined, trans-4-aminomethyl-cyclohexanecarbonylphenylalanine-4- carboxyanilide (peptide 16) inhibited PK with a high selectivity and an IC50 value of 2.7 μM, being as potent as PKSI-527.
View MoreContact:86-21-34622192,13917187091,21-34622765
Address:No. 500 Caobao Road Shanghai P.R China
Nantong LiKai Chemical Co.,Ltd
Contact:+86-513-89068669
Address:Jincheng Science Park
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
NINGBO PANGS CHEM INT’L CO., LTD.
Contact:+86-0574-27666801
Address:Floor 21, Building 11, Xintiandi, No. 689, Shijiroad, Ningbo, Zhejiang, China
Suzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Doi:10.1246/bcsj.34.1846
(1961)Doi:10.1002/jhet.5570350235
(1998)Doi:10.1134/S1070363219040169
(2019)Doi:10.1021/jo9803434
(1998)Doi:10.1016/S0040-4039(01)00101-0
(2001)Doi:10.1021/ja01340a054
(1932)